Actinium Pharmaceuticals, Inc.ATNMNYSE
Loading
Total debt minus cash and cash equivalents
Latest
$-71.33M
↓ 49% vs avg
Percentile
P21
Within normal range
Streak
2 yr
Consecutive growthCompressed
Average
$-47.71M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $-71.33M | +4.3% |
| 2023 | $-74.56M | +29.9% |
| 2022 | $-106.33M | -37.2% |
| 2021 | $-77.52M | -23.3% |
| 2020 | $-62.87M | -703.4% |
| 2019 | $-7.83M | +41.6% |
| 2018 | $-13.41M | +22.9% |
| 2017 | $-17.40M | +15.2% |
| 2016 | $-20.52M | +19.1% |
| 2015 | $-25.38M | - |